Richard Lehman’s journal review—19 January 2015
NEJM 15 Jan 2015 Vol 372 201 “The main challenge is to ensure better systems [of sharing data] for the future. Because ‘the optimal systematic review would have complete information […]
NEJM 15 Jan 2015 Vol 372 201 “The main challenge is to ensure better systems [of sharing data] for the future. Because ‘the optimal systematic review would have complete information […]
NEJM 8 Jan 2015 Vol 372 113 A vaccine that works really well is the best kind of medical intervention. But a vaccine that gives partial protection is a headache. […]
JAMA 24-31 December 2014 Vol 312 2659 The effects of extreme heat on older adults: what a great topic for this cold gloomy time of the year. “Heat wave periods […]
NEJM 18 December 2014 Vol 371 2353 Try to make winter bearable by thinking of the joys of late spring, such as seeing laburnum trees in full blossom. But you […]
NEJM 11 December 2014 Vol 371 OL The clones! The clones! There is something of Edgar Allen Poe about this study, which describes how “clonal hematopoiesis with somatic mutations is […]
NEJM 4 December 2014 Vol 371 2227 “We need to remember that these drugs also have toxic effects, they are enormously and inappropriately expensive, and they haven’t cured anyone yet. […]
NEJM 27 November 2014 Vol 371 2061 Antoine Bernard-Jean Marfan (1858-1942) was a French paediatrician who lived in the happy era of medicine when you could affix your name to […]
NEJM 20 November 2014 Vol 371 1963 The melanoma trials last week got me thinking about how the current model of cancer drug research lets down trial participants and dying […]
NEJM 13 November 2014 Vol 371 1867 “Metastatic melanoma remains just over the border of curability. As we wait and hope for some breakthrough in an agonizingly incremental process, there […]
NEJM 6 November 2014 Vol 371 1771 The first paper in the New England Journal this week describes a French trial of rituximab versus azathioprine for maintenance in ANCA associated […]